Site

Search results

  1. RJ Reynold’s Unpublished Randomized Controlled Trial Finds that Camel Snus is Not Effective for Smoking Cessation

    We just submitted this public comment to the FDA.  The tracking number is 1k0-8ob6-gewv. (PDF version)   RJ Reynold’s Unpublished Randomized Controlled Trial Finds that Camel Snus is Not Effective for Smoking Cessation   Docket No. FDA-2016-N-0073   Eunice E. Neeley, MD, MPH, Lauren K. Lempert, JD, MPH, ...

  2. CDPH's proposed rule for medical marijuana labeling and formulations will not prevent industry abuses

    We just submitted this public comment on California's proposed regulations on medical marijuana labeling and formulations.  A PDF of the comment which includes the graphic elements is available here.   Instructions for submitting public comments on emergency cannabis regulations: ...

  3. HUD overstated costs and vastly understated the benefits of ending smoking in (some) public housing

    you think will get lung cancer because they smoke? (If “don’t know,” PROBE ‘Just your best guess will ...

  4. To minimize illicit tobacco trade, FDA should reject any partnership with the tobacco industry, reject industry estimates and exaggeration of illicit trade, and use the FCTC Protocol on Illicit Trade as a model to counter the supply side of illicit trade

    My colleagues and I just submitted this public comment to the FDA.  The tracking number is 1k2-93fq-mfpc.  A PDF (including all the footnotes) is here.   To minimize illicit tobacco trade, FDA should reject any partnership with the tobacco industry, reject industry estimates and exaggeration of illicit ...

  5. R.J. Reynolds Tobacco Company’s Application for Six Camel SNUS Smokeless Tobacco Minimizes its Appeal to Adolescents and the Likelihood that Youth and Adolescents Will Initiate Smokeless Tobacco or Smokeless Tobacco with Other Products

    and sensation expectations before experimentation. Adding flavors to smokeless tobacco does just that. ...

  6. Swedish Match's revised MRTP application didn't adequately address FDA's questions; FDA should deny its application to make reduced risk claims

    My colleagues at UCSF, Georgia State University, and Stanford just submitted this public comment to FDA.  The tracking number on Regulations.gov is 1k3-97pu-m56t.  A PDF of the comment is here.  We also submitted this comment to TPSAC for its consideration; this letter, which summarizes the main points ...

  7. Public comment we submitted to the California Dept of Health on Proposed Marijuana Regulation: Too Lax to Protect Public Health

    not just by the user, but also by any children in the home. The tobacco industry has long recognized ...

  8. Stanton Glantz, PhD

    adults (not just teens) as targets for the tobacco industry and efforts at smoking cessation and tobacco ...

  9. Esteban G. Burchard, MD, MPH

    Just AC, Breton C, Reese SE, Markunas CA, Richmond RC, Xu CJ, Küpers LK, Oh SS, Hoyo C, Gruzieva O, ...

  10. FAMRI Clinic

    The FAMRI Bland Lane Center of Excellence on Second Hand Smoke at UCSF has just launched an online ...

Pages